Cargando…
Clinical picture and outcome of Serious Adverse Events in the treatment of Onchocerciasis
Ivermectin (Mectizan(®)) is the only drug currently recommended for the treatment and control of onchocerciasis. Serious adverse events rarely occur during treatment, except in subjects heavily infected with Loa Loa. This review of drug-related serious adverse events in the treatment of onchocercias...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2003
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2147654/ https://www.ncbi.nlm.nih.gov/pubmed/14975063 http://dx.doi.org/10.1186/1475-2883-2-S1-S6 |